AM

Amanda M.

Head Of People & Culture at Custom Pharma Services

Amanda M. is an experienced HR professional with a robust career at Custom Pharma Services since July 2010, progressing from HR Administrator to Head of People & Culture. In the current role, Amanda advises the leadership team on business culture and HR policies. Previous positions include HR Manager and Senior HR Adviser, focusing on compliance with employment legislation and effective HR process management. Earlier career highlights include HR roles at East Sussex Fire and Rescue Service and mBlox Ltd, providing payroll and HR administration support across multiple regions. Amanda holds a BSc in Industrial Systems and Business Management from the University of Westminster.

Location

Grays, United Kingdom

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Custom Pharma Services

1 followers

Custom Pharma Services is located in Brighton, UK since 1979 and is a full-service contract development and manufacturing organisation (CDMO) providing services tailored to your needs, no matter how niche or complex. Custom covers the full spectrum of activities from development through commercial manufacturing for both clinical and commercial use. Specialising in Oral Solid Dosage forms with the ability to handle highly potent drugs and poorly bioavailable compounds Custom really is your one stop resource. With direct access to highly skilled experts offering a partnership approach Custom Pharma Services truly has a molecule first mentality, managing all projects with the end in mind. Custom Can! • Custom Pharma is a CDMO offering clinical and commercial manufacturing of tablets, capsules, powders (oral-solid-dose) for human use. • Services comprise pre-formulation and formulation development, analytical development, stability testing, clinical trial material manufacturing • Commercial Production • Pre-clinical formulation development and solubilisation • Material characterisation • Drug in capsule approach to accelerate early clinical studies • Specialists in low dosage (sub-mg) formulations • Contained manufacturing for highly potent APIs • Orphan drug development • Formulation development of poorly soluble drugs, including spray drying capabilities


Employees

51-200

Links